These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20414718)

  • 1. Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network.
    Cox B; Ballard-Barbash R; Broeders M; Dowling E; Malila N; Shumak R; Taplin S; Buist D; Miglioretti D;
    Breast Cancer Res Treat; 2010 Dec; 124(3):793-800. PubMed ID: 20414718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International comparison of performance measures for screening mammography: can it be done?
    Yankaskas BC; Klabunde CN; Ancelle-Park R; Renner G; Wang H; Fracheboud J; Pou G; Bulliard JL;
    J Med Screen; 2004; 11(4):187-93. PubMed ID: 15624239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical quality control practices in mammography screening programs in 22 countries.
    Hendrick RE; Klabunde C; Grivegnee A; Pou G; Ballard-Barbash R
    Int J Qual Health Care; 2002 Jun; 14(3):219-26. PubMed ID: 12108532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control of mammography screening in the Veneto Region. Evaluation of four programs at a local health unit level--analysis of the frequency and diagnostic pattern of interval cancers.
    Vettorazzi M; Stocco C; Chirico A; Recanatini S; Saccon S; Mariotto R; Cinquetti S; Moretto T; Sartori P; Stomeo A; Ciatto S
    Tumori; 2006; 92(1):1-5. PubMed ID: 16683376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of breast cancer screening behavior in women with a strong family history of the disease.
    Price MA; Butow PN; Charles M; Bullen T; Meiser B; McKinley JM; McLachlan SA; Phillips KA; ;
    Breast Cancer Res Treat; 2010 Nov; 124(2):509-19. PubMed ID: 20364401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries.
    Klabunde CN; Sancho-Garnier H; Taplin S; Thoresen S; Ohuchi N; Ballard-Barbash R;
    Int J Qual Health Care; 2002 Dec; 14(6):449-61. PubMed ID: 12515331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating regional Hospital Information System data through comparison with a local cancer register to identify interval cancers of a breast screening program.
    Sperati A; Pannozzo F; Giorgi Rossi P; Baiocchi D; Barca A; Borgia P
    Eur J Cancer Prev; 2009 Jun; 18(3):212-5. PubMed ID: 19238084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
    Santen R
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study.
    Suhrke P; Zahl PH
    Cancer Med; 2015 Aug; 4(8):1303-8. PubMed ID: 25991514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study.
    Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M; Patnick J
    BMJ; 2004 May; 328(7451):1291-2. PubMed ID: 15166064
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of hormone replacement therapy on the accuracy of screening mammography.
    Vernet Mdel M; Checa MA; Macià F; Casamitjana M; Carreras R
    Breast J; 2006; 12(2):154-8. PubMed ID: 16509841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study guided by the Health Belief Model of the predictors of breast cancer screening of women ages 40 and older.
    Fulton JP; Buechner JS; Scott HD; DeBuono BA; Feldman JP; Smith RA; Kovenock D
    Public Health Rep; 1991; 106(4):410-20. PubMed ID: 1908592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer, mammography screening and hormone therapy].
    Nielsen M
    Ugeskr Laeger; 2004 Aug; 166(34):2915. PubMed ID: 15449536
    [No Abstract]   [Full Text] [Related]  

  • 18. [Breast cancer, mammography screening and hormone therapy].
    Ersbøll J
    Ugeskr Laeger; 2004 Aug; 166(36):3113-4. PubMed ID: 15387316
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer screening--the European experience.
    Perry NM
    Int J Fertil Womens Med; 2004; 49(5):228-30. PubMed ID: 15633481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
    Kriege M; Brekelmans CT; Obdeijn IM; Boetes C; Zonderland HM; Muller SH; Kok T; Manoliu RA; Besnard AP; Tilanus-Linthorst MM; Seynaeve C; Bartels CC; Kaas R; Meijer S; Oosterwijk JC; Hoogerbrugge N; Tollenaar RA; Rutgers EJ; de Koning HJ; Klijn JG
    Breast Cancer Res Treat; 2006 Nov; 100(1):109-19. PubMed ID: 16791481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.